Stegmaier K - Search Results

1

CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2.

Chen L, Alexe G, Dharia NV, Ross L, Iniguez AB, Conway AS, Wang EJ, Veschi V, Lam N, Qi J, Gustafson WC, Nasholm N, Vazquez F, Weir BA, Cowley GS, Ali LD, Pantel S, Jiang G, Harrington WF, Lee Y, Goodale A, Lubonja R, Krill-Burger JM, Meyers RM, Tsherniak A, Root DE, Bradner JE, Golub TR, Roberts CW, Hahn WC, Weiss WA, Thiele CJ, Stegmaier K. Chen L, et al. Among authors: stegmaier k. J Clin Invest. 2018 Jan 2;128(1):446-462. doi: 10.1172/JCI90793. Epub 2017 Dec 4. J Clin Invest. 2018. PMID: 29202477 Free PMC article.

2

Involvement of the TEL gene in hematologic malignancy by diverse molecular genetic mechanisms.

Golub TR, Barker GF, Stegmaier K, Gilliland DG. Golub TR, et al. Among authors: stegmaier k. Curr Top Microbiol Immunol. 1996;211:279-88. doi: 10.1007/978-3-642-85232-9_28. Curr Top Microbiol Immunol. 1996. PMID: 8585959 Review. No abstract available.

3

Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia.

Stegmaier K, Takeuchi S, Golub TR, Bohlander SK, Bartram CR, Koeffler HP. Stegmaier K, et al. Cancer Res. 1996 Mar 15;56(6):1413-7. Cancer Res. 1996. PMID: 8640833

4

The TEL gene and human leukemia.

Golub TR, McLean T, Stegmaier K, Carroll M, Tomasson M, Gilliland DG. Golub TR, et al. Among authors: stegmaier k. Biochim Biophys Acta. 1996 Aug 8;1288(1):M7-10. doi: 10.1016/0304-419x(96)00015-7. Biochim Biophys Acta. 1996. PMID: 8764840 Review. No abstract available.

5

The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms.

Golub TR, Barker GF, Stegmaier K, Gilliland DG. Golub TR, et al. Among authors: stegmaier k. Curr Top Microbiol Immunol. 1997;220:67-79. doi: 10.1007/978-3-642-60479-9_5. Curr Top Microbiol Immunol. 1997. PMID: 9103676 Review. No abstract available.

6

Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation.

Stegmaier K, Ross KN, Colavito SA, O'Malley S, Stockwell BR, Golub TR. Stegmaier K, et al. Nat Genet. 2004 Mar;36(3):257-63. doi: 10.1038/ng1305. Epub 2004 Feb 8. Nat Genet. 2004. PMID: 14770183

7

Gefitinib induces myeloid differentiation of acute myeloid leukemia.

Stegmaier K, Corsello SM, Ross KN, Wong JS, Deangelo DJ, Golub TR. Stegmaier K, et al. Blood. 2005 Oct 15;106(8):2841-8. doi: 10.1182/blood-2005-02-0488. Epub 2005 Jul 5. Blood. 2005. PMID: 15998836 Free PMC article.

8

A method for high-throughput gene expression signature analysis.

Peck D, Crawford ED, Ross KN, Stegmaier K, Golub TR, Lamb J. Peck D, et al. Among authors: stegmaier k. Genome Biol. 2006;7(7):R61. doi: 10.1186/gb-2006-7-7-r61. Genome Biol. 2006. PMID: 16859521 Free PMC article.

9

Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators.

Hieronymus H, Lamb J, Ross KN, Peng XP, Clement C, Rodina A, Nieto M, Du J, Stegmaier K, Raj SM, Maloney KN, Clardy J, Hahn WC, Chiosis G, Golub TR. Hieronymus H, et al. Among authors: stegmaier k. Cancer Cell. 2006 Oct;10(4):321-30. doi: 10.1016/j.ccr.2006.09.005. Epub 2006 Sep 28. Cancer Cell. 2006. PMID: 17010675 Free article.

10

Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.

Stegmaier K, Wong JS, Ross KN, Chow KT, Peck D, Wright RD, Lessnick SL, Kung AL, Golub TR. Stegmaier K, et al. PLoS Med. 2007 Apr;4(4):e122. doi: 10.1371/journal.pmed.0040122. PLoS Med. 2007. PMID: 17425403 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters